Back

Human epididymis protein 4 indicates progression of cardiac fibrosis in Heart Failure with preserved Ejection Fraction.

28 August 2022 (17:15 - 17:45)
Organised by:
Congress Presentation Part of: Targeting remodeling of the injured heart Fibrosis ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Naoya Nakashima

Kumamoto University Hospital, Kumamoto (Japan)

4 More presentations in this session

Presentation thumbnail
The administration of valproic acid exerts a protective effect by reducing the infarct size and the triggering of ventricular fibrillation in an experimental model of chronic myocardial infarction
Miss P. Genoves (Valencia, ES)
Abstract Slides
Presentation thumbnail
The regenerative response of cardiac interstitial cells
Doctor C. Jopling (Montpellier, FR)
Abstract Slides
Presentation thumbnail
Deficiency of pituitary adenylate cyclase-activating peptide and its receptor PAC1 confers interstitial cardiac fibrosis in a murine model of metabolic stress
Mr J. Schubart (Kassel, DE)
Abstract Slides
Presentation thumbnail
Cardiac sympathetic afferent denervation reduces matrix metalloproteinase expression and improves cardiac remodeling in rats post myocardial infarction
Professor I. Zucker (Omaha, US)
Abstract Slides

Access the full session

Session thumbnail
Targeting remodeling of the injured heart

The Event

Event poster

ESC Congress 2022

28 August 2022 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact and reversibility of cardiac fibrosis across the spectrum of heart failure
thumbnail
Congress Presentation
Imaging in heart failure: what about myocardial fibrosis?
thumbnail
Congress Session
Young Investigator Award Basic and Translational Science

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources